calendar
58 catalysts · 18 phase 2 completion · 15 phase 1 completion · 8 phase 1 initiation · 7 phase 2 initiation · 5 phase 0 trial completion · 2 phase 3 initiation
next 91 dayslessmore
MonWedFri
58 catalysts · 18 phase 2 completion · 15 phase 1 completion · 8 phase 1 initiation · 7 phase 2 initiation · 5 phase 0 trial completion · 2 phase 3 initiation
Therapy area: Cardiovascular, Oncology. Indication: Diffuse Large B-Cell Lymphoma, Hematological Tumor, Leukemia, Lymphoma, Multiple Myeloma (Kahler Disease), Myeloproliferative Disorders, Pulmonary Embolism, Thromboembolic Disease, Venous Thromboembolism
Therapy area: Cardiovascular. Indication: Acute Ischemic Stroke, Cerebral Infarction (Brain Infarction)
Therapy area: Cardiovascular. Indication: Hypotension
Therapy area: Cardiovascular, Genito Urinary System, Infectious Disease. Indication: Acute Renal Failure (ARF) (Acute Kidney Injury), Sepsis, Septic Shock
Therapy area: Cardiovascular. Indication: Myocardial Infarction
Therapy area: Genito Urinary System, Immunology. Indication: Delayed Graft Function (DGF), End-Stage Kidney Disease (End-Stage Renal Disease or ESRD)
Therapy area: Cardiovascular. Indication: Acute Ischemic Stroke, Ischemic Stroke
Therapy area: Immunology. Indication: Inflammation